Dividend Harvesting Portfolio Week 227: $22,700 Allocated, $2,385.24 In Projected DividendsSeeking Alpha • 07/10/25
Healthy Returns: Medicaid cuts in Trump's megabill may affect some drugmakers more than othersCNBC • 07/08/25
Boomers Are Grabbing These Big Beautiful Blue-Chip Dividend Giants For Decades of Passive Income24/7 Wall Street • 07/07/25
Time to Sell the Rally and Buy These 5% and Higher Blue-Chip Dividend Giants24/7 Wall Street • 06/30/25
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb's Cell Therapy LabelsBusiness Wire • 06/27/25
This Once Dominant Dividend Stock May Be About to Come Back to Life in July24/7 Wall Street • 06/26/25
Will New Drugs Enable BMY to Offset the Impact of Generic Competition?Zacks Investment Research • 06/25/25
Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?Zacks Investment Research • 06/20/25
Bristol Myers Squibb (BMY) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 06/16/25